Associate
Alexander (Zan) Newkirk's practice encompasses patent litigation, prosecution, and client counseling in the chemical, pharmaceutical, and medical device areas. He has industry experience with pulmonary and nasal medical devices, drug formulation, and vaccine formulation development.
Zan's litigation experience covers various aspects of trial preparation, including discovery and regular pre-trial activities. He has worked on ANDA (Abbreviated New Drug Application) litigation.
Prior to law school, Zan interned at Novavax, a vaccine development company, where he analyzed influenza and RSV (Respiratory Syncytial Virus) vaccines using laboratory techniques such as DLS (Dynamic Light Scattering) particle sizing, ELISA (Enzyme-Linked Immunosorbent Assay), and SDS-PAGE (Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis). Shortly thereafter, he began work at Catalent, a drug development company, where he analyzed inhaler and nebulizer products using HPLC (High Performance Liquid Chromatography) and GC/MS (Gas Chromatography/Mass Spectrometry).
In law school, Zan served on the executive board of the University of North Carolina at Chapel Hill's Intellectual Property Law Association and wrote for the North Carolina Journal of Law and Technology.
Pro bono work is a vital part of Zan's practice. Cases he has worked on include juvenile resentencing and asylum cases. Zan has been recognized on the Capital Pro Bono High Honor Roll.
Articles
Southeast Litigation Update: January 2024 Southeast Litigation Update: January 2024
March 7, 2024
Articles
Southeast Litigation Update: November 2023 Southeast Litigation Update: November 2023
January 5, 2024
Articles
Southeast Litigation Update: September and October 2023 Southeast Litigation Update: September and October 2023
December 18, 2023
Articles
2021 Natural Products Field Manual - Obtaining Patent Rights 2021 Natural Products Field Manual - Obtaining Patent Rights
July 2021
Natural Products ConsultingArticles
In-House Considerations in Advice of Counsel Defense In-House Considerations in Advice of Counsel Defense
May 26, 2021
Westlaw TodayFederal Circuit IP Blog
No Standing on Appeal from PTAB Where Appellant Cannot Prove Injury in Fact No Standing on Appeal from PTAB Where Appellant Cannot Prove Injury in Fact
April 20, 2021
Award/Ranking
60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll 60 Finnegan Attorneys Named to 2023 Capital Pro Bono Honor Roll
May 15, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.